| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |